Related Experiment Video
Updated: Jul 11, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barre syndrome
S K Velioğlu1, M Ozmenoğlu, C Boz
1Karadeniz Technical University, Medical Faculty, Neurology Department, Trabzon, Turkey.
Intravenous immunoglobulin (IVIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndrome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome.
Intravenous immunoglobulin (IVIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndrome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Encephalitis ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology

